New York State Common Retirement Fund
JNCE

New York State Common Retirement Fund’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

New York State Common Retirement Fund’s Portfolio JNCE Stock Details JNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-15,468
Closed -$28.6K – 3485
2023
Q1 		$28.6K Hold
15,468
– – ﹤0.01% 3074
2022
Q4 		$17.2K Hold
15,468
– – ﹤0.01% 3194
2022
Q3 		$36K Buy
15,468
+134
+0.9% +$475 ﹤0.01% 3180
2022
Q2 		$46K Sell
15,334
-38
-0.2% -$185 ﹤0.01% 3222
2022
Q1 		$104K Sell
15,372
-26,334
-63% -$188K ﹤0.01% 3010
2021
Q4 		$348K Sell
41,706
-413
-1% -$3.4K ﹤0.01% 2633
2021
Q3 		$313K Buy
42,119
+198
+0.5% +$1.23K ﹤0.01% 2702
2021
Q2 		$285K Sell
41,921
-7,013
-14% -$58.3K ﹤0.01% 2879
2021
Q1 		$503K Hold
48,934
– – ﹤0.01% 2461
2020
Q4 		$343K Sell
48,934
-700
-1% -$5.45K ﹤0.01% 2527
2020
Q3 		$405K Hold
49,634
– – ﹤0.01% 2316
2020
Q2 		$342K Buy
49,634
+15,278
+44% +$82.4K ﹤0.01% 2408
2020
Q1 		$163K Buy
34,356
+12,222
+55% +$70.4K ﹤0.01% 2561
2019
Q4 		$193K Sell
22,134
-600
-3% -$3.24K ﹤0.01% 2753
2019
Q3 		$76K Buy
22,734
+1,150
+5% +$4.6K ﹤0.01% 3096
2019
Q2 		$107K Sell
21,584
-500
-2% -$2.65K ﹤0.01% 3072
2019
Q1 		$137K Sell
22,084
-400
-2% -$1.93K ﹤0.01% 2868
2018
Q4 		$76K Sell
22,484
-300
-1% -$1.4K ﹤0.01% 3026
2018
Q3 		$148K Hold
22,784
– – ﹤0.01% 2955
2018
Q2 		$175K Sell
22,784
-150
-0.7% -$2.16K ﹤0.01% 2932
2018
Q1 		$513K Hold
22,934
– – ﹤0.01% 2343
2017
Q4 		$292K Buy
22,934
+17,434
+317% +$256K ﹤0.01% 2596
2017
Q3 		$86K Hold
5,500
– – ﹤0.01% 3019
2017
Q2 		$77K Buy
+5,500
New +$118K ﹤0.01% 3120

Other funds holding JNCE

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

New York State Common Retirement Fund's JNCE Position: Q2 2023 in Review

New York State Common Retirement Fund sold out of Jounce Therapeutics, Inc. Common Stock (JNCE) in Q2 2023, closing a stake of 15,468 shares — an estimated $28.6K sold.

New York State Common Retirement Fund first reported a position in JNCE in Q2 2017 and held it in 24 quarters. The position peaked at $513K in Q1 2018. 1 fund tracked by Wall St. Rank holds JNCE as of Q2 2023.

  • New York State Common Retirement Fund reported no remaining Jounce Therapeutics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • New York State Common Retirement Fund sold 15,468 Jounce Therapeutics, Inc. Common Stock shares in Q2 2023, an estimated $28.6K.
  • New York State Common Retirement Fund first reported a position in Jounce Therapeutics, Inc. Common Stock in Q2 2017 and held it in 24 quarters.
  • New York State Common Retirement Fund's Jounce Therapeutics, Inc. Common Stock position peaked at $513K in Q1 2018.
  • 1 fund tracked by Wall St. Rank held Jounce Therapeutics, Inc. Common Stock as of Q2 2023.

Based on New York State Common Retirement Fund's 13F filing for Q2 2023, filed 7 Aug 2023.